In-Depth Focus from IDWeek 2017: Skin Infections Frequent Emergency Medicine Decision-Making Factors in ABSSSI Treatment

Frequent Emergency Medicine Decision-Making Factors in ABSSSI Treatment

Clinical factors such as severity of infection on presentation and underlying comorbidities were the main factors influencing treatment decisions.

In-Depth Focus from IDWeek 2017: Skin Infections Dalbavancin Safe and Effective for ABSSSI in Patients With SIRS

Dalbavancin Safe and Effective for ABSSSI in Patients With SIRS

Dalbavancin is an effective and well-tolerated treatment for ABSSSI, including in patients who met SIRS criteria.

In-Depth Focus from IDWeek 2017: Skin Infections Ceftaroline Fosamil Associated With Shorter ABSSSI-Related Hospital Stay

Ceftaroline Fosamil Associated With Shorter ABSSSI-Related Hospital Stay

Compared with vancomycin, patients with ABSSSI treated with ceftaroline fosamil had significantly shorter length of hospital stay.

In-Depth Focus from IDWeek 2017: Skin Infections Effect of Omadacycline on Cardiac Parameters in ABSSSI and CABP

Effect of Omadacycline on Cardiac Parameters in ABSSSI and CABP

Omadacycline was non-inferior to moxifloxacin for treatment of CABP and linezolid for treatment of ABSSSI.

In-Depth Focus from IDWeek 2017: Skin Infections Omadacycline Noninferior to Linezolid in ABSSSI Patients With High BMI, Diabetes

Omadacycline Noninferior to Linezolid in ABSSSI Patients With High BMI, Diabetes

The goal of this post-hoc analysis of OASIS-1 study was to determine if BMI or T2D had any effect on the efficacy or safety of omadacycline relative to linezolid.

In-Depth Focus from IDWeek 2017: Skin Infections Intramuscular Benzathine Penicillin Reduced Incidence of Recurrent Cellulitis

Intramuscular Benzathine Penicillin Reduced Incidence of Recurrent Cellulitis

Although intramuscular antibiotics had been suggested as a prevention strategy for recurrent cellulitis, the evidence is scarce.

In-Depth Focus from IDWeek 2017: Skin Infections Worse Outcomes With Acute Skin Plus Bloodstream Infections

Worse Outcomes With Acute Skin Plus Bloodstream Infections

Researchers evaluated risk factors associated with secondary bloodstream infections in patients with acute bacterial skin and skin structure infections.

In-Depth Focus from IDWeek 2017: Skin Infections Treating ABSSSI in Diabetes: Efficacy of Dalbavancin Examined

Treating ABSSSI in Diabetes: Efficacy of Dalbavancin Examined

Dalbavancin has shown potent activity against gram-positive pathogens responsible for ABSSSI, including MRSA.

In-Depth Focus from IDWeek 2017: Skin Infections Fournier's Gangrene: Incidence, Risk Factors, and Adverse Outcomes

Fournier's Gangrene: Incidence, Risk Factors, and Adverse Outcomes

Study suggests a higher incidence of Fournier's gangrene than previously described.

In-Depth Focus from IDWeek 2017: Skin Infections Cost Effectiveness of Dalbavancin, Oritavancin in Acute Skin Infections

Cost Effectiveness of Dalbavancin, Oritavancin in Acute Skin Infections

Dalbavancin and oritavancin may make it possible to allow for earlier discharge and reduce health care costs without compromising efficacy.

Upcoming Meetings

Sign Up for Free e-newsletters